相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni et al.
NATURE (2018)
Immune checkpoint inhibitors and elderly people: A review
Amaury Daste et al.
EUROPEAN JOURNAL OF CANCER (2017)
Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 Expression
Dan A. Erkes et al.
JOURNAL OF IMMUNOLOGY (2017)
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang et al.
NATURE (2017)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
J. Weber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Proliferation of PD-1+CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients
Alice O. Kamphorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
Alexandre Reuben et al.
NPJ GENOMIC MEDICINE (2017)
Cancer Immunotherapy in Older Patients
Kristen A. Marrone et al.
CANCER JOURNAL (2017)
Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
Sagun Parakh et al.
BRITISH JOURNAL OF CANCER (2017)
Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy
K. A. Ahmed et al.
ANNALS OF ONCOLOGY (2016)
Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy
K. A. Ahmed et al.
ANNALS OF ONCOLOGY (2016)
Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis
Tomohiro F. Nishijima et al.
CANCER TREATMENT REVIEWS (2016)
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Frank A. Schildberg et al.
IMMUNITY (2016)
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
Sarah B. Goldberg et al.
LANCET ONCOLOGY (2016)
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros et al.
NATURE MEDICINE (2016)
Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development
Xiaomin Yu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Diversity and clonal selection in the human T-cell repertoire
Qian Qi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Impact of a Large and Frequent Deletion in the Human TCR β Locus on Antiviral Immunity
Rebekah M. Brennan et al.
JOURNAL OF IMMUNOLOGY (2012)
Impact of Epitope Escape on PD-1 Expression and CD8 T-Cell Exhaustion during Chronic Infection
Joseph N. Blattman et al.
JOURNAL OF VIROLOGY (2009)
Systemic effects of local radiotherapy
Silvia C. Formenti et al.
LANCET ONCOLOGY (2009)
Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals
N Khan et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
